146 related articles for article (PubMed ID: 36440122)
1. Synthesis and Anticancer Evaluation of Novel Indole Based Arylsulfonylhydrazides against Human Breast Cancer Cells.
Gaur A; Peerzada MN; Khan NS; Ali I; Azam A
ACS Omega; 2022 Nov; 7(46):42036-42043. PubMed ID: 36440122
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, Anticancer Evaluation, Enzymatic Assays, and a Molecular Modeling Study of Novel Pyrazole-Indole Hybrids.
Hassan AS; Moustafa GO; Awad HM; Nossier ES; Mady MF
ACS Omega; 2021 May; 6(18):12361-12374. PubMed ID: 34056388
[TBL] [Abstract][Full Text] [Related]
3. Indole-Acrylonitrile Derivatives as Potential Antitumor and Antimicrobial Agents-Synthesis, In Vitro and In Silico Studies.
Kornicka A; Gzella K; Garbacz K; Jarosiewicz M; Gdaniec M; Fedorowicz J; Balewski Ł; Kokoszka J; Ordyszewska A
Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513830
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt.
Abo-Salem HM; Gibriel AA; El Awady ME; Mandour AH
Med Chem; 2021; 17(2):158-170. PubMed ID: 32141421
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
8. Facile synthesis of C6-substituted benz[4,5]imidazo[1,2-a]quinoxaline derivatives and their anticancer evaluation.
Singh R; Kumar R; Pandrala M; Kaur P; Gupta S; Tailor D; Malhotra SV; Salunke DB
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2000393. PubMed ID: 33749032
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 2-amino-4-(5'-substituted 2'-phenyl-1H-indol-3'-yl)-6-aryl-4H-pyran-3-carbonitrile derivatives as antimicrobial and antioxidant agents.
Saundane AR; Vijaykumar K; Vaijinath AV
Bioorg Med Chem Lett; 2013 Apr; 23(7):1978-84. PubMed ID: 23454016
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents.
Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH
Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418
[TBL] [Abstract][Full Text] [Related]
11. Molecular Docking and In Vitro Anticancer Screening of Synthesized Arylthiazole linked 2H-indol-2-one Derivatives as VEGFR-2 Kinase Inhibitors.
Shalmali N; Bawa S; Ali MR; Kalra S; Kumar R; Zeya B; Rizvi MA; Partap S; Husain A
Anticancer Agents Med Chem; 2022; 22(11):2166-2180. PubMed ID: 34792005
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, molecular docking and in silico ADMET profile of pyrano[2,3-d]pyrimidine derivatives as antimicrobial and anticancer agents.
Abd El-Sattar NEA; El-Adl K; El-Hashash MA; Salama SA; Elhady MM
Bioorg Chem; 2021 Oct; 115():105186. PubMed ID: 34314914
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Anticancer Activity of Indole-Functionalized Derivatives of Betulin.
Rzepka Z; Bębenek E; Chrobak E; Wrześniok D
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365190
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel 1-oxo-1,2,3,4-tetrahydropyrazino[1,2-a]indole-3-carboxamide analogs in MCF-7 and MDA-MB-468 breast cancer cell lines.
Kim YJ; Pyo JS; Jung YS; Kwak JH
Bioorg Med Chem Lett; 2017 Feb; 27(3):607-611. PubMed ID: 27993518
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antitumor activity and structure-activity studies of novel pyridoxine-based bioisosteric analogs of estradiol.
Pugachev MV; Pavelyev RS; Nguyen TNT; Gabbasova RR; Bulatov TM; Iksanova AG; Aljondi B; Bondar OV; Grishaev DY; Yamaleeva ZR; Kataeva ON; Nikishova TV; Balakin KV; Shtyrlin YG
Bioorg Med Chem; 2021 Jan; 30():115957. PubMed ID: 33373820
[TBL] [Abstract][Full Text] [Related]
19. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-proliferative activity of aromatic substituted 5-((1-benzyl-1H-indol-3-yl)methylene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione analogs against human tumor cell lines.
Madadi NR; Penthala NR; Janganati V; Crooks PA
Bioorg Med Chem Lett; 2014 Jan; 24(2):601-3. PubMed ID: 24361000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
